Country Risk Report Q4 2021 - Academic

Covid-19 mRNA vaccine booster outlook positive despite heart inflammation risk

Pfizer drew headlines this month when it raised the idea of an emergency authorization for its COVID-19 mRNA vaccine booster to combat the Delta variant. But what does this mean for its rare heart inflammation side effects?